Sources told ET that online pharmacy startup PharmEasy could hit the bourses this year, two years after its previous attempt. The company w...

Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore los...

Reliance Retail's Isha Ambani and Parita Parekh from Toddle are the youngest women in the inaugural 2024 Hurun India Under35s list. The lis...

Pai is also joining the board of PharmEasy and is expected to work with CEO Shah. He will retain the board seats as long as his holding doe...

The online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4

PharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per ...

The board notified its shareholders about increasing the authorised share capital to Rs 3,500 crore (about $423.72 million), divided into 3...

Mumbai-based epharmacy platform PharmEasy is likely to be valued at $500-600 million compared to the $5.6 billion valuation in 2021

The Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...

PharmEasy founders — Siddharth Shah, Dhaval Shah, Dhramil Sheth, Harsh Parekh and Hardik Dedhia — have received new stock options ahead of ...

Zomato's blockbuster IPO—among the biggest for the Indian stock markets—not only received major institutional capital but also stirred mass...

The ET Startup of the Year will be characterised by breakthrough innovation, top-class execution and fast-paced growth. The quality of the ...

Talks on with Amansa, Blackstone, OrbiMed and others as e-pharmacy eyes IPO at $7-8 billion valuation.

PharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of whi...

PharmEasy claims to be India’s number one online pharmacy and diagnostics brand. Thyrocare prides itself as the largest diagnostic company.

Boards of two firms believed to have given in-principle nod for an all-stock transaction.

Ascent Health is eyeing up to 10 acquisitions by the end of the current fiscal, according to the company’s CEO Siddharth Shah.